Valuation: AstraZeneca PLC

Market Cap 241B 1,259B 208B 196B 178B 334B 22,977B 340B 2,292B 896B 11,523B 904B 884B 38,335B P/E 2026 *
19.9x
P/E 2027 * 17.3x
Enterprise Value 260B 1,360B 225B 211B 192B 361B 24,821B 367B 2,476B 968B 12,448B 976B 955B 41,411B EV / Sales 2026 *
4.11x
EV / Sales 2027 * 3.78x
Free-Float
96.63%
Yield 2026 *
2.14%
Yield 2027 * 2.27%
1 day+0.20%
1 week-0.25%
Current month-5.26%
1 month-4.45%
3 months-10.97%
6 months-24.12%
Current year-19.23%
1 week 133.75
Extreme 133.75
138.2
1 month 130.06
Extreme 130.06
149.01
Current year 130.06
Extreme 130.06
190.4
1 year 130.02
Extreme 130.02
190.4
3 years 101.6
Extreme 101.6
190.4
5 years 93.74
Extreme 93.74
190.4
10 years 93.74
Extreme 93.74
190.4
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%-0.25% - - 241B
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.01%+0.43%+27.15%+42.67% 399.46B
Weighted average by Cap. -1.26%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 63.25B 331B 54.65B 51.4B 46.7B 87.73B 6,035B 89.24B 602B 235B 3,027B 237B 232B 10,069B 66.85B 349B 57.76B 54.33B 49.36B 92.73B 6,379B 94.32B 636B 249B 3,199B 251B 246B 10,643B
Net income 12.07B 63.08B 10.43B 9.81B 8.91B 16.74B 1,152B 17.03B 115B 44.89B 578B 45.3B 44.33B 1,921B 13.72B 71.68B 11.85B 11.15B 10.13B 19.02B 1,309B 19.35B 131B 51.01B 656B 51.47B 50.37B 2,183B
Net Debt 19.33B 101B 16.7B 15.71B 14.27B 26.81B 1,844B 27.27B 184B 71.88B 925B 72.53B 70.98B 3,077B 11.66B 60.93B 10.07B 9.48B 8.61B 16.17B 1,112B 16.45B 111B 43.36B 558B 43.75B 42.82B 1,856B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
14/08/26 R$136.22 +0.17% 864
13/08/26 R$135.99 +0.03% 104
12/08/26 R$135.95 -0.23% 1,065
11/08/26 R$136.26 -1.00% 65
10/08/26 R$137.63 +0.78% 48
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
155.26USD
Average target price
211.68USD
Spread / Average Target
+36.34%

Quarterly revenue - Rate of surprise